News

Harrow, the manufacturer of TRIESENCE, hopes to expand the on-label usage of TRIESENCE for all cataract surgery patients.

Bausch + Lomb has issued a voluntary recall of several of its intraocular lenses.

Health record data was evaluated by researchers looking for the potential risk of diabetic retinopathy progression following non-complex cataract surgery.

Cataracts are the leading cause of vision loss in the United States with an estimated 20 million Americans over the age of 40 dealing with cataracts in one or both eyes.

Light Adjustable Lenses are a type of intraocular lens (IOL) made by RxSIGHT® that is the first and only lens available that offers customization after cataract surgery.

Researchers at the Wilmer Eye Institute have created a clear hydrogel that turns fluorescent green under blue light. This color change allows surgeons to confirm that they have removed all of the h...

Study results were recently presented at the annual meeting of the American Academy of Ophthalmology that reveal an increased risk of post cataract surgery complications for patients with a histor...

Patients who have had prior intravitreal injects may be at a higher risk of postoperative complications after cataract surgery according to study results published from researchers at the Universit...

Results from the Phase 3 OPTIMIZE-1 trial of OCS-01, a once-daily, preservative-free corticosteroid eye drop, were presented at the 2024 ASCRS Annual Meeting.